Clinical trial
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young…
NCT00317408 · European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma, Other · Unknown status
Key facts
| NCT number | NCT00317408 |
|---|---|
| Title | Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma |
| Official title | Treatment Protocol for Relapsed Anaplastic Large Cell Lymphoma of Childhood and Adolescence |
| Lead sponsor | European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | anti-thymocyte globulin, busulfan, carboplatin, carmustine, cyclosporine, cytarabine, dexamethasone, etoposide phosphate, idarubicin, ifosfamide and 13 more |
| Enrollment | 96 |
| Start date | Apr 1, 2004 |
| Primary completion | Feb 1, 2014 |
| First posted | Apr 24, 2006 |
| Last update posted | Sep 25, 2015 |
| Countries | Austria, Belgium, Czechia, France, Germany, Ireland, Italy, Netherlands, Poland, Sweden, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: